Conagra Beat Earnings — But Wall Street Still Won't Call It a Turnaround

Conagra Brands just delivered a quarter that beat expectations on nearly every line that matters to the bottom line. The stock barely moved, and Wall Street's price targets tell you why investors aren't fully buying the recovery story yet.

The packaged foods company reported adjusted earnings per share of $0.41 for its fiscal first quarter, blowing past the $0.28 consensus estimate by $0.13. Revenue came in at $2.60 billion, slightly ahead of the $2.59 billion analysts expected. Reported diluted EPS of $0.36 was up 5.9% from a year ago.

The catch: that beat came alongside a 1.4% decline in overall net sales and a 1.1% drop in organic net sales, driven by a 2.1% decrease in volume that price increases only partially offset. Conagra is managing to grow profit even as the top line shrinks — not the easiest trick to pull off, but one the company is leaning into deliberately.

CEO John Brase framed it as a strategy playing out on schedule rather than a company losing ground.

"We delivered a solid start to fiscal 2027 with top line results largely in line with expectations and profit ahead of expectations amid a challenging operating environment." — John Brase, President and CEO, Conagra Brands

Brase pointed to four specific priorities the company says are starting to show up in the numbers: restoring margins, increasing investment, reducing complexity, and rebalancing capital allocation. Conagra reaffirmed its full fiscal 2027 guidance of organic net sales change between negative 3% and negative 1%, adjusted operating margin of 10.0% to 10.5%, and adjusted EPS of $1.40 to $1.50.

There were real bright spots buried in the segment data. Conagra gained dollar share in frozen vegetables, pudding, chili, frozen breakfast, hot dogs, and frozen desserts — categories where the company is fighting hard against both private label and rival brands. Equity method investment earnings jumped 71.8% to $50 million, helped by favorable conditions at the Ardent Mills joint venture.

Here's where the stock tip gets interesting for income-focused investors: Conagra declared a quarterly dividend of $0.175 per share, payable December 3 to shareholders of record as of November 5. At current prices, that works out to roughly a 5.1% annualized yield — a meaningful number in a market where high-quality dividend payers aren't exactly cheap.

That yield is also the risk. Shares traded down to $13.77 after the report, within a one-year range of $12.53 to $20.32, and multiple analysts have reiterated cautious stances even after the earnings beat. UBS raised its target modestly to $14.00 from $13.00 with a Neutral rating. Deutsche Bank moved to $13.00 from $12.00 with a Hold. Barclays was more constructive, lifting its target to $17.00 from $16.00 with an Overweight call — but the stock's consensus rating still skews toward "Reduce," with an average price target around $14.13, barely above where shares currently sit.

For investors considering CAG here, the entry case is mostly about the dividend and the valuation — shares are down meaningfully from their 52-week high, and the beat-and-reaffirm quarter at least removes near-term guidance risk. The catalyst to watch is whether organic sales volume stabilizes in the next two quarters; if it does, this starts looking like a legitimate value name rather than a yield trap.

The risk cuts the other way too. A negative 17% net margin and a debt-to-equity ratio north of 1.0 mean there isn't much room for error if the turnaround plan stalls. This is a name for patient investors comfortable collecting a solid dividend while the company proves out its margin-recovery thesis one quarter at a time — not a momentum trade.

Bottom line: Conagra beat the numbers that move headlines, but the market is still asking for proof the underlying business is actually growing again — and that answer won't come until volume trends turn positive.